Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Immuno-oncology Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-oncology Therapy Market Perspective (2018-2029)
2.2 Immuno-oncology Therapy Growth Trends by Region
2.2.1 Global Immuno-oncology Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immuno-oncology Therapy Historic Market Size by Region (2018-2024)
2.2.3 Immuno-oncology Therapy Forecasted Market Size by Region (2024-2029)
2.3 Immuno-oncology Therapy Market Dynamics
2.3.1 Immuno-oncology Therapy Industry Trends
2.3.2 Immuno-oncology Therapy Market Drivers
2.3.3 Immuno-oncology Therapy Market Challenges
2.3.4 Immuno-oncology Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-oncology Therapy Players by Revenue
3.1.1 Global Top Immuno-oncology Therapy Players by Revenue (2018-2024)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-oncology Therapy Revenue
3.4 Global Immuno-oncology Therapy Market Concentration Ratio
3.4.1 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2022
3.5 Immuno-oncology Therapy Key Players Head office and Area Served
3.6 Key Players Immuno-oncology Therapy Product Solution and Service
3.7 Date of Enter into Immuno-oncology Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-oncology Therapy Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Historic Market Size by Type (2018-2024)
4.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029)
5 Immuno-oncology Therapy Breakdown Data by Application
5.1 Global Immuno-oncology Therapy Historic Market Size by Application (2018-2024)
5.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immuno-oncology Therapy Market Size (2018-2029)
6.2 North America Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immuno-oncology Therapy Market Size by Country (2018-2024)
6.4 North America Immuno-oncology Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-oncology Therapy Market Size (2018-2029)
7.2 Europe Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immuno-oncology Therapy Market Size by Country (2018-2024)
7.4 Europe Immuno-oncology Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-oncology Therapy Market Size (2018-2029)
8.2 Asia-Pacific Immuno-oncology Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-oncology Therapy Market Size (2018-2029)
9.2 Latin America Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immuno-oncology Therapy Market Size by Country (2018-2024)
9.4 Latin America Immuno-oncology Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-oncology Therapy Market Size (2018-2029)
10.2 Middle East & Africa Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-oncology Therapy Introduction
11.1.4 Amgen Revenue in Immuno-oncology Therapy Business (2018-2024)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-oncology Therapy Introduction
11.2.4 AstraZeneca Revenue in Immuno-oncology Therapy Business (2018-2024)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Detail
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-oncology Therapy Introduction
11.4.4 Eli-Lilly Revenue in Immuno-oncology Therapy Business (2018-2024)
11.4.5 Eli-Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-oncology Therapy Introduction
11.5.4 Roche Revenue in Immuno-oncology Therapy Business (2018-2024)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2018-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Detail
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-oncology Therapy Introduction
11.7.4 Janssen Biotech Revenue in Immuno-oncology Therapy Business (2018-2024)
11.7.5 Janssen Biotech Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-oncology Therapy Introduction
11.8.4 Merck Revenue in Immuno-oncology Therapy Business (2018-2024)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-oncology Therapy Introduction
11.9.4 Novartis Revenue in Immuno-oncology Therapy Business (2018-2024)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-oncology Therapy Introduction
11.10.4 Pfizer Revenue in Immuno-oncology Therapy Business (2018-2024)
11.10.5 Pfizer Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-oncology Therapy Introduction
11.11.4 Sanofi Revenue in Immuno-oncology Therapy Business (2018-2024)
11.11.5 Sanofi Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Detail
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2018-2024)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-oncology Therapy Introduction
11.13.4 Takeda Revenue in Immuno-oncology Therapy Business (2018-2024)
11.13.5 Takeda Recent Development
11.14 BioNTech SE
11.14.1 BioNTech SE Company Detail
11.14.2 BioNTech SE Business Overview
11.14.3 BioNTech SE Immuno-oncology Therapy Introduction
11.14.4 BioNTech SE Revenue in Immuno-oncology Therapy Business (2018-2024)
11.14.5 BioNTech SE Recent Development
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Detail
11.15.2 Allogene Therapeutics Business Overview
11.15.3 Allogene Therapeutics Immuno-oncology Therapy Introduction
11.15.4 Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024)
11.15.5 Allogene Therapeutics Recent Development
11.16 IMAB-I-Mab Biopharma Co., Ltd.
11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Detail
11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Introduction
11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2018-2024)
11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Development
11.17 Arcus Biosciences
11.17.1 Arcus Biosciences Company Detail
11.17.2 Arcus Biosciences Business Overview
11.17.3 Arcus Biosciences Immuno-oncology Therapy Introduction
11.17.4 Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2018-2024)
11.17.5 Arcus Biosciences Recent Development
11.18 Gritstone Oncology
11.18.1 Gritstone Oncology Company Detail
11.18.2 Gritstone Oncology Business Overview
11.18.3 Gritstone Oncology Immuno-oncology Therapy Introduction
11.18.4 Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2018-2024)
11.18.5 Gritstone Oncology Recent Development
11.19 Autolus Therapeutics
11.19.1 Autolus Therapeutics Company Detail
11.19.2 Autolus Therapeutics Business Overview
11.19.3 Autolus Therapeutics Immuno-oncology Therapy Introduction
11.19.4 Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024)
11.19.5 Autolus Therapeutics Recent Development
11.20 Rubius Therapeutics
11.20.1 Rubius Therapeutics Company Detail
11.20.2 Rubius Therapeutics Business Overview
11.20.3 Rubius Therapeutics Immuno-oncology Therapy Introduction
11.20.4 Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024)
11.20.5 Rubius Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immuno-oncology Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immune Checkpoint Inhibitors
Table 4. Key Players of Immune System Modulators
Table 5. Key Players of Cancer Vaccines
Table 6. Global Immuno-oncology Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Immuno-oncology Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Immuno-oncology Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Immuno-oncology Therapy Market Share by Region (2018-2024)
Table 10. Global Immuno-oncology Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Immuno-oncology Therapy Market Share by Region (2024-2029)
Table 12. Immuno-oncology Therapy Market Trends
Table 13. Immuno-oncology Therapy Market Drivers
Table 14. Immuno-oncology Therapy Market Challenges
Table 15. Immuno-oncology Therapy Market Restraints
Table 16. Global Immuno-oncology Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Immuno-oncology Therapy Market Share by Players (2018-2024)
Table 18. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Table 19. Ranking of Global Top Immuno-oncology Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Immuno-oncology Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immuno-oncology Therapy Product Solution and Service
Table 23. Date of Enter into Immuno-oncology Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immuno-oncology Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Immuno-oncology Therapy Revenue Market Share by Type (2018-2024)
Table 27. Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Immuno-oncology Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Immuno-oncology Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Immuno-oncology Therapy Revenue Market Share by Application (2018-2024)
Table 31. Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Immuno-oncology Therapy Revenue Market Share by Application (2024-2029)
Table 33. North America Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Immuno-oncology Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. Amgen Company Detail
Table 49. Amgen Business Overview
Table 50. Amgen Immuno-oncology Therapy Product
Table 51. Amgen Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 52. Amgen Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Immuno-oncology Therapy Product
Table 56. AstraZeneca Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Bristol-Myers Squibb Company Detail
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Immuno-oncology Therapy Product
Table 61. Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 62. Bristol-Myers Squibb Recent Development
Table 63. Eli-Lilly Company Detail
Table 64. Eli-Lilly Business Overview
Table 65. Eli-Lilly Immuno-oncology Therapy Product
Table 66. Eli-Lilly Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 67. Eli-Lilly Recent Development
Table 68. Roche Company Detail
Table 69. Roche Business Overview
Table 70. Roche Immuno-oncology Therapy Product
Table 71. Roche Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 72. Roche Recent Development
Table 73. GlaxoSmithKline Company Detail
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Immuno-oncology Therapy Product
Table 76. GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Janssen Biotech Company Detail
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Immuno-oncology Therapy Product
Table 81. Janssen Biotech Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 82. Janssen Biotech Recent Development
Table 83. Merck Company Detail
Table 84. Merck Business Overview
Table 85. Merck Immuno-oncology Therapy Product
Table 86. Merck Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Novartis Company Detail
Table 89. Novartis Business Overview
Table 90. Novartis Immuno-oncology Therapy Product
Table 91. Novartis Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Pfizer Company Detail
Table 94. Pfizer Business Overview
Table 95. Pfizer Immuno-oncology Therapy Product
Table 96. Pfizer Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Sanofi Company Detail
Table 99. Sanofi Business Overview
Table 100. Sanofi Immuno-oncology Therapy Product
Table 101. Sanofi Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Spectrum Pharmaceuticals Company Detail
Table 104. Spectrum Pharmaceuticals Business Overview
Table 105. Spectrum Pharmaceuticals Immuno-oncology Therapy Product
Table 106. Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 107. Spectrum Pharmaceuticals Recent Development
Table 108. Takeda Company Detail
Table 109. Takeda Business Overview
Table 110. Takeda Immuno-oncology Therapy Product
Table 111. Takeda Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 112. Takeda Recent Development
Table 113. BioNTech SE Company Detail
Table 114. BioNTech SE Business Overview
Table 115. BioNTech SE Immuno-oncology Therapy Product
Table 116. BioNTech SE Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 117. BioNTech SE Recent Development
Table 118. Allogene Therapeutics Company Detail
Table 119. Allogene Therapeutics Business Overview
Table 120. Allogene Therapeutics Immuno-oncology Therapy Product
Table 121. Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 122. Allogene Therapeutics Recent Development
Table 123. IMAB-I-Mab Biopharma Co., Ltd. Company Detail
Table 124. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
Table 125. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product
Table 126. IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 127. IMAB-I-Mab Biopharma Co., Ltd. Recent Development
Table 128. Arcus Biosciences Company Detail
Table 129. Arcus Biosciences Business Overview
Table 130. Arcus Biosciences Immuno-oncology Therapy Product
Table 131. Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 132. Arcus Biosciences Recent Development
Table 133. Gritstone Oncology Company Detail
Table 134. Gritstone Oncology Business Overview
Table 135. Gritstone Oncology Immuno-oncology Therapy Product
Table 136. Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 137. Gritstone Oncology Recent Development
Table 138. Autolus Therapeutics Company Detail
Table 139. Autolus Therapeutics Business Overview
Table 140. Autolus Therapeutics Immuno-oncology Therapy Product
Table 141. Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 142. Autolus Therapeutics Recent Development
Table 143. Rubius Therapeutics Company Detail
Table 144. Rubius Therapeutics Business Overview
Table 145. Rubius Therapeutics Immuno-oncology Therapy Product
Table 146. Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2024) & (US$ Million)
Table 147. Rubius Therapeutics Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-oncology Therapy Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Immuno-oncology Therapy Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Immune Checkpoint Inhibitors Features
Figure 5. Immune System Modulators Features
Figure 6. Cancer Vaccines Features
Figure 7. Global Immuno-oncology Therapy Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Immuno-oncology Therapy Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Center Case Studies
Figure 11. Others Case Studies
Figure 12. Immuno-oncology Therapy Report Years Considered
Figure 13. Global Immuno-oncology Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Immuno-oncology Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Immuno-oncology Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Immuno-oncology Therapy Market Share by Players in 2022
Figure 17. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Immuno-oncology Therapy Revenue in 2022
Figure 19. North America Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 21. United States Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 25. Germany Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Immuno-oncology Therapy Market Share by Region (2018-2029)
Figure 33. China Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 41. Mexico Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Immuno-oncology Therapy Market Share by Country (2018-2029)
Figure 45. Turkey Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Immuno-oncology Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Amgen Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 48. AstraZeneca Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 50. Eli-Lilly Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 51. Roche Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 53. Janssen Biotech Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 54. Merck Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 55. Novartis Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 56. Pfizer Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 57. Sanofi Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 58. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 59. Takeda Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 60. BioNTech SE Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 61. Allogene Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 62. IMAB-I-Mab Biopharma Co., Ltd. Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 63. Arcus Biosciences Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 64. Gritstone Oncology Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 65. Autolus Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 66. Rubius Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed